- Home
- LVLU vs BME Comparison
LVLU vs BME Comparison
Compare LVLU & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LVLU | BME |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4M | 536.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LVLU | BME |
|---|---|---|
| Price | $4.90 | $40.58 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 26.3K | ★ 34.0K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $285,413,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.53 | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.98 | $35.53 |
| 52 Week High | $18.00 | $43.20 |
Technical Indicators
Market Signals| Indicator | LVLU | BME |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 55.29 |
| Support Level | $5.00 | $39.81 |
| Resistance Level | $5.13 | $41.12 |
| Average True Range (ATR) | 0.41 | 0.41 |
| MACD | -0.06 | -0.10 |
| Stochastic Oscillator | 0.00 | 40.05 |
Price Performance
Historical ComparisonAbout LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.